Clearmind Medicine completes treatment for 18 participants in phase 1 trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Clearmind Medicine completes treatment for 18 participants in phase 1 trial
(NASDAQ: CMND) Delayed: 2.30 -0.08 (3.36%)
Previous Close $2.38    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.42    P/E N/A 
Day Low $2.04    EPS $ 
Volume 4,918,652